Your new post is loading...
Researchers in Luxembourg have uncovered a new approach for shrinking tumours. Their findings, recently published in the Molecular Oncology Journal, outlines a potent immunotherapy combination. This combination involves pairing a STING agonist, which enhances the immune system, with a compound that targets autophagy, a mechanism implicated in cancer immune evasion. This dual therapeutic approach markedly reduced tumour size and improved survival rates in preclinical studies, offering new hope of shifting the paradigm in cancer treatment.
Learn more / En savoir plus / Mehr erfahren:
https://www.scoop.it/t/luxembourg-europe/?&tag=Health
https://www.scoop.it/topic/luxembourg-europe/?&tag=Cancer
Researchers in Luxembourg have uncovered a new approach for shrinking tumours. Their findings, recently published in the Molecular Oncology Journal, outlines a potent immunotherapy combination. This combination involves pairing a STING agonist, which enhances the immune system, with a compound that targets autophagy, a mechanism implicated in cancer immune evasion. This dual therapeutic approach markedly reduced tumour size and improved survival rates in preclinical studies, offering new hope of shifting the paradigm in cancer treatment.
Learn more / En savoir plus / Mehr erfahren:
https://www.scoop.it/t/luxembourg-europe/?&tag=Health
https://www.scoop.it/topic/luxembourg-europe/?&tag=Cancer